BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 30617490)

  • 1. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.
    Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC
    Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine.
    Wagner M; Schilling R; Doeblin P; Huppertz A; Luhur R; Schwenke C; Maurer M; Hamm B; Taupitz M; Durmus T
    Eur Radiol; 2013 Jan; 23(1):108-14. PubMed ID: 22772150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.
    Muehlberg F; Arnhold K; Fritschi S; Funk S; Prothmann M; Kermer J; Zange L; von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
    J Cardiovasc Magn Reson; 2018 Feb; 20(1):13. PubMed ID: 29458430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular volume-guided late gadolinium enhancement analysis for non-ischemic cardiomyopathy: The Women's Interagency HIV Study.
    Kato Y; Kizer JR; Ostovaneh MR; Lazar J; Peng Q; van der Geest RJ; Lima JAC; Ambale-Venkatesh B
    BMC Med Imaging; 2021 Jul; 21(1):116. PubMed ID: 34315432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.
    Lee CH; Vellayappan B; Taupitz M; Hamm B; Asbach P
    Eur Radiol; 2019 Dec; 29(12):6982-6990. PubMed ID: 31264013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar.
    Francis R; Kellman P; Kotecha T; Baggiano A; Norrington K; Martinez-Naharro A; Nordin S; Knight DS; Rakhit RD; Lockie T; Hawkins PN; Moon JC; Hausenloy DJ; Xue H; Hansen MS; Fontana M
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):91. PubMed ID: 29162123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved border sharpness of post-infarct scar by a novel self-navigated free-breathing high-resolution 3D whole-heart inversion recovery magnetic resonance approach.
    Rutz T; Piccini D; Coppo S; Chaptinel J; Ginami G; Vincenti G; Stuber M; Schwitter J
    Int J Cardiovasc Imaging; 2016 Dec; 32(12):1735-1744. PubMed ID: 27549804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput gadobutrol-enhanced CMR: a time and dose optimization study.
    D'Angelo T; Grigoratos C; Mazziotti S; Bratis K; Pathan F; Blandino A; Elen E; Puntmann VO; Nagel E
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):83. PubMed ID: 29110679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic late gadolinium enhancement cardiac magnetic resonance for diagnosing myocardial scar.
    Abdula G; Nickander J; Sörensson P; Lundin M; Kellman P; Sigfridsson A; Ugander M
    Scand Cardiovasc J; 2018 Jun; 52(3):127-132. PubMed ID: 29544374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of dark-blood late gadolinium enhancement cardiovascular magnetic resonance without additional magnetization preparation.
    Holtackers RJ; Van De Heyning CM; Nazir MS; Rashid I; Ntalas I; Rahman H; Botnar RM; Chiribiri A
    J Cardiovasc Magn Reson; 2019 Jul; 21(1):44. PubMed ID: 31352900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of two dark blood methods of late gadolinium quantification of ischemic scar.
    Foley JRJ; Broadbent DA; Fent GJ; Garg P; Brown LAE; Chew PG; Dobson LE; Swoboda PP; Plein S; Higgins DM; Greenwood JP
    J Magn Reson Imaging; 2019 Jul; 50(1):146-152. PubMed ID: 30604492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Efficacy of Reduced-Dose Gadobutrol Versus Standard-Dose Gadoterate for Contrast-Enhanced MRI of the CNS: An International Multicenter Prospective Crossover Trial (LEADER-75).
    Liu BP; Rosenberg M; Saverio P; Weon YC; Peters S; Ardellier FD; Boeckenhoff A; Endrikat J
    AJR Am J Roentgenol; 2021 Nov; 217(5):1195-1205. PubMed ID: 34133205
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthetic multi-contrast late gadolinium enhancement imaging using post-contrast magnetic resonance fingerprinting.
    Rashid I; Al-Kindi S; Rajagopalan V; Walker J; Rajagopalan S; Seiberlich N; Hamilton JI
    NMR Biomed; 2024 Jan; 37(1):e5043. PubMed ID: 37740596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR Angiography at 3 T of Peripheral Arterial Disease: A Randomized Prospective Comparison of Gadoterate Meglumine and Gadobutrol.
    Loewe C; Arnaiz J; Krause D; Marti-Bonmati L; Haneder S; Kramer U;
    AJR Am J Roentgenol; 2015 Jun; 204(6):1311-21. PubMed ID: 26001243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
    Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
    J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of enhancement of the vestibular perilymph between gadoterate meglumine and gadobutrol at 3-Tesla in Meniere's disease.
    Eliezer M; Poillon G; Gillibert A; Horion J; Cruypeninck Y; Gerardin E; Magne N; Attyé A
    Diagn Interv Imaging; 2018 May; 99(5):271-277. PubMed ID: 29398574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dark-blood late gadolinium enhancement without additional magnetization preparation.
    Holtackers RJ; Chiribiri A; Schneider T; Higgins DM; Botnar RM
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):64. PubMed ID: 28835250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.